Search Results for: prostate cancer

Gen-Probe announced that the Company has submitted a Premarket Approval Application (PMA) to the FDA for its PROGENSA PCA3 assay.

A blood test at the age of 60 can accurately predict the risk that a man will die from prostate cancer within the next 25 years, according to researchers at Memorial Sloan-Kettering Cancer Center, in New York, and Lund University, in Sweden.

Experts at The University of Texas MD Anderson Cancer Center advise men to keep a record of their prostate specific antigen (PSA) test results to help determine if they are at increased risk for prostate cancer.

Miraculins Inc announces the launch of its PSP94 Immunoassay for urine specimens, a research use only (RUO) tool utilizing enzyme linked immunosorbent assay (ELISA) for the detection of PSP94 in urine.